Insider Transactions in Q1 2023 at Homology Medicines, Inc. (FIXX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2023
|
Paul Alloway |
SELL
Open market or private sale
|
Direct |
10,965
-39.63%
|
$10,965
$1.45 P/Share
|
|
Jan 09
2023
|
Arthur Tzianabos |
SELL
Open market or private sale
|
Direct |
10,616
-8.92%
|
$10,616
$1.39 P/Share
|
|
Jan 09
2023
|
Albert Seymour |
SELL
Open market or private sale
|
Direct |
3,620
-2.47%
|
$3,620
$1.39 P/Share
|
|
Jan 09
2023
|
W Bradford Smith Officer |
SELL
Open market or private sale
|
Direct |
3,729
-20.78%
|
$3,729
$1.39 P/Share
|
|
Jan 09
2023
|
Paul Alloway |
SELL
Open market or private sale
|
Direct |
3,090
-13.32%
|
$3,090
$1.39 P/Share
|
|
Jan 09
2023
|
Michael Lee Blum Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,454
-15.35%
|
$2,454
$1.39 P/Share
|
|
Jan 01
2023
|
Paul Alloway |
BUY
Exercise of conversion of derivative security
|
Direct |
9,570
+18.93%
|
-
|
|
Jan 01
2023
|
W Bradford Smith Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,530
+32.66%
|
-
|
|
Jan 01
2023
|
Albert Seymour |
BUY
Exercise of conversion of derivative security
|
Direct |
11,220
+3.74%
|
-
|
|
Jan 01
2023
|
Arthur Tzianabos |
BUY
Exercise of conversion of derivative security
|
Direct |
33,000
+13.02%
|
-
|
|
Jan 01
2023
|
Michael Lee Blum Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,590
+21.47%
|
-
|